Median levels of ANG, ANGST, 8-iso-PGF2α, SNCG, and IL-13 were 9.5-fold, 7-fold, 1.4-fold, 1.3-fold, and 1.8-fold higher, respectively, in the subgroup of primary BC patients compared with the control group. The gene discussed is IL13; the disease is breast cancer.